Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
November 14, 2017
Patent Application Number
15587127
Date Filed
May 4, 2017
Patent Citations Received
Patent Primary Examiner
Patent abstract
The present disclosure relates to compositions of daclizumab suitable for subcutaneous administration and methods of manufacturing thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
